Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 15,268 $ 87,721
Marketable securities, current 36,147 10,234
Prepaid expenses 2,340 2,244
Grants revenue receivable 5,591 4,329
Accounts receivable from related party 0 240
In-process research and development - held for sale 4,500 26,623
Other current assets 300 95
Total current assets 64,146 131,486
Operating lease right-of-use assets, non-current 10,397 0
Property and equipment, net 13,884 6,851
Other assets 4,735 1,821
Total assets 93,162 140,158
Current liabilities:    
Accounts payable 1,414 780
Accrued liabilities 9,105 5,357
Deferred revenue, current 11,956 26,231
Other current liabilities 1,623 141
Total current liabilities 24,098 32,509
Deferred revenue, non-current 1,236 2,670
Long-term debt, non-current, net 3,001 3,254
Operating lease liabilities, non-current 10,573 0
Other liabilities 1,238 819
Total liabilities 40,146 39,252
Commitments and contingencies (Note 9)
Stockholders’ equity    
Common stock, $0.001 par value: Authorized: 150,000,000 shares; issued and outstanding: 36,954,510 shares at September 30, 2019 and 36,736,012 shares at December 31, 2018 37 37
Additional paid-in capital 201,203 195,573
Accumulated other comprehensive income 20 0
Accumulated deficit (148,244) (94,704)
Total stockholders’ equity 53,016 100,906
Total liabilities and stockholders’ equity $ 93,162 $ 140,158